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Abstract
Streptococcus pneumoniae (the pneumococcus) continues to account for significant mor-
bidity and mortality worldwide, causing life-threatening diseases such as pneumonia, bac-
teremia and meningitis, as well as less serious infections such as sinusitis, conjunctivitis
and otitis media. Current polysaccharide vaccines are strictly serotype-specific and also
drive the emergence of non-vaccine serotype strains. In this study, we used microarray
analysis to compare gene expression patterns of either serotype 4 or serotype 6A pneumo-
cocci in the nasopharynx and blood of mice, as a model to identify genes involved in inva-
sion of blood in the context of occult bacteremia in humans. In this manner, we identified 26
genes that were significantly up-regulated in the nasopharynx and 36 genes that were sig-
nificantly up-regulated in the blood that were common to both strains. Gene Ontology classi-
fication revealed that transporter and DNA binding (transcription factor) activities constitute
the significantly different molecular functional categories for genes up-regulated in the naso-
pharynx and blood. Targeted mutagenesis of selected genes from both niches and subse-
quent virulence and pathogenesis studies identified the manganese-dependent superoxide
dismutase (SodA) as most likely to be essential for colonization, and the cell wall-associ-
ated serine protease (PrtA) as important for invasion of blood. This work extends our previ-
ous analyses and suggests that both PrtA and SodA warrant examination in future studies
aimed at prevention and/or control of pneumococcal disease.
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Introduction
Streptococcus pneumoniae (the pneumococcus) is a formidable human pathogen, responsible
for significant morbidity and mortality worldwide. It causes a broad spectrum of diseases rang-
ing from less serious infections such as sinusitis, conjunctivitis and otitis media, to potentially
fatal diseases such as pneumonia, bacteraemia and meningitis. The burden of pneumococcal
disease is greatest in developing countries, where an estimated 1.1 million children under 5
years of age die each year from pneumonia (approximately 20% of all deaths in this age group),
of which S. pneumoniae is the single commonest cause [1]. The continuing problem of pneu-
mococcal disease is partly attributable to the rate at which this organism is acquiring resistance
to multiple antimicrobials and the rapid global spread of highly resistant clones [2]. The prob-
lem is being exacerbated by the major shortcomings associated with the current capsular poly-
saccharide-based vaccines, including cost, strictly serotype-specific protection, incomplete
serotype coverage, and replacement carriage and disease caused by non-vaccine serotypes [3].
Concerted global efforts are focused on accelerating the development of alternative pneumococ-
cal vaccine strategies that address the shortcomings of existing approaches, without compromising
efficacy. One such approach involves a detailed assessment of pneumococcal proteins that contrib-
ute to pathogenesis and are common to all serotypes, their development as vaccine antigens, and
an understanding of the mechanism whereby protection might be elicited. The virulence proteins
which have received the greatest attention and shown consistent promise as vaccine candidates to
date include the thiol-activated toxin pneumolysin (Ply), two choline-binding surface proteins
called pneumococcal surface protein A (PspA) and choline-binding protein A (CbpA) (also
referred to as PspC or SpsA), iron uptake protein PiuA and various combinations thereof [4–11].
Additional candidate proteins have been identified and appraised for inclusion in multi-com-
ponent pneumococcal protein vaccine formulations. These include autolysin (LytA) [12], heat-
shock protein ClpP [13], neuraminidase A (NanA) [14, 15], pili (RrgA, RrgB, RrgC) [16], the
polyhistidine triad (Pht) proteins (particularly PhtD) [6, 17–19], PotD [20], StkP and PcsB [21].
Experimental multivalent protein vaccines are currently being optimized to obtain the best for-
mulation that could confer sufficiently synergistic protection against a wider variety of S. pneu-
moniae strains to warrant clinical development as an alternative to existing conjugate vaccines.
As part of these activities, we carried out systematic microarray comparisons of gene expression
kinetics of two pneumococcal strains (WCH16 [serotype 6A] andWCH43 [serotype 4]) in the
nasopharynx, lungs, blood and brain of mice. The analyses yielded a number of niche-specific,
up-regulated genes that contribute to pathogenesis, some of which were shown to encode good
vaccine candidates [22, 23]. However, direct comparisons of gene expression profiles of these
pneumococci between the nasopharynx and blood is yet to be reported, although in early child-
hood, this direct transition to blood is a complication of pneumococcal carriage [24]. We
hypothesized that pneumococcal genes that are consistently up-regulated in the blood relative
to nasopharynx are likely to be important for survival and/or virulence, while those that are con-
sistently up-regulated in the nasopharynx relative blood are likely to be genes that are important
for colonization. In order to test this hypothesis, we carried out comparison of pneumococcal
gene expression patterns between the nasopharynx and blood using existing transcriptomic data
derived from the two S. pneumoniae strains after intranasal challenge of mice.
Materials and Methods
Ethics Statement
Outbred 5- to 6-week-old sex-matched CD1 (Swiss) mice, obtained from the Laboratory Ani-
mal Services breeding facility of the University of Adelaide, were used in all experiments. The
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of London; www.bugs.sgul.ac.uk) for supply of the
microarray slides and advice and The Wellcome
Trust for funding the multi-collaborative microbial
pathogen microarray facility under its Functional
Genomics Resources Initiative. The funders had no
role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Animal Ethics Committee of The University of Adelaide approved all animal experiments
(approval numbers S-2010-001 and S-2013-053). The study was conducted in compliance with
the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes (7th
Edition 2004) and the South Australian Animal Welfare Act 1985.
Bacterial strains and growth conditions
The pneumococcal strains used in this study are serotype 4 (WCH43), serotype 6A (WCH16),
and their otherwise isogenic mutant derivatives (Table 1). Serotype-specific capsule production
was confirmed by Quellung reaction, as described previously [25]. Opaque-phase variants of
the three strains, selected on Todd-Hewitt broth supplemented with 1% yeast extract (THY)-
catalase plates [26], were used in all animal experiments. Before infection, the bacteria were
grown statically at 37°C in serum broth (10% heat-inactivated horse serum in nutrient broth)
to A600 of 0.16 (equivalent to approx. 5 × 10
7 CFU/ml).
Intranasal challenge of mice and extraction of total pneumococcal RNA
The protocols used for mouse challenge and analysis of in vivo gene expression by WCH16
andWCH43 have been described in detail previously [22, 23]. Briefly, groups of female mice
were challenged intranasally (i.n.) with either WCH16 or WCH43 under anaesthesia. For the
current study, RNA was extracted from pneumococci harvested from the nasopharynx and
blood of at least 12 mice at each of 48, 72 and 96 h post-challenge using acid-phenol–chloro-
form–isoamyl alcohol (125:24:1; pH 4.5; Ambion) and purified using RNeasy minikit (Qiagen).
The experiment was performed three times for each strain.
Transcriptomic analyses
Microarray experiments were performed on whole genome S. pneumoniae PCR arrays
obtained from the Bacterial Microarray Group at St George's Hospital Medical School, London
(http://bugs.sghms.ac.uk/). The array was designed using TIGR4 base strain annotation [27]
and extra target genes from strain R6 [28]. The array design is available in BμG@Sbase (Acces-
sion No. A-BUGS-14; http://bugs.sgul.ac.uk/A-BUGS-14) and also GEO (Platform GPL4001).
Pair-wise comparisons were made between the nasopharynx and blood RNA samples from the
48, 72 and 96 h time points. RNA samples were reverse-transcribed using Superscript III (Invi-
trogen), labeled with either Alexa Fluor 546 or Alexa Fluor 647 dye using the 3DNA Array 900
MPX labeling kit (Genisphere) and then hybridized to the surface of the microarray, essentially
as described [29, 30]. Slides were scanned at 10 μm resolution using a Genepix 4000B Scanner
(Molecular Devices, USA) and spots were analyzed using the Spot plugin (CSIRO, Australia)
within the R statistical software package (http://www.R-project.org). The Limma plugin for R
[31] was used for data processing and statistical analysis and ratio values were normalized
using the print-tip Loess normalization routine [32]. The replicate arrays were normalized to
each other to give similar ranges of mRNA expression values. These statistics were used to rank
the mRNAs from those most likely to be differentially expressed to the least likely using false-
discovery rate values of p< 0.05. A two-sample Bayesian t-test was also used to analyze the
transcriptomic data [33] using FlexArray software (McGill University, Canada), and values
with a p = 0.05 were considered to be statistically significant. In this manner, microarray analy-
sis examining RNA from infected nasopharynx vs blood was performed on at least 9 indepen-
dent hybridizations for each strain, including at least one dye reversal per comparison.
Pneumococcal Genes in Carriage and Blood Invasion
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Gene Ontology (GO) classification and GO-based network construction
To gain a detailed view and a better understanding of the functions of the differentially regu-
lated pneumococcal genes in the nasopharynx and blood, we carried out gene ontology (GO)
classification and network analysis of the genes using our recently developed comparative GO
web application [34]. Particular attention was paid to “molecular function” and “biological
process” GO categories. Data from GO protein distributions were analyzed by two-sample Kol-
mogorov–Smirnov (K–S) and Goodness-of-Fit (Chi-square) tests [35]. We also utilized the
information from the GO analysis for selection of genes subjected to mutation.
Construction of mutants and assessment of bacterial growth in vitro
Defined, non-polar mutants of selected genes of interest were constructed in strains WCH16
andWCH43. Selection criteria included known or putative contribution to pneumococcal
metabolism, pathogenesis and virulence. Mutants were constructed by overlap extension PCR
Table 1. S. pneumoniae strains and primers used in this study.
Strain/Primer Description (Sequence type) Source/Reference
WCH16 Capsular serotype 6A clinical isolate (4966) Women’s and Children’s Hospital, North Adelaide,
Australia
WCH43 Capsular serotype 4 clinical isolate (205) Women’s and Children’s Hospital, North Adelaide,
Australia
WCH16::ΔprtA prtA deletion mutant of WCH16 [EryR] Present study
WCH16::ΔsodA sodA deletion mutant of WCH16 [EryR] Present study
WCH16::ΔvanZ vanZ deletion mutant of WCH16 [SpecR] Present study
WCH43::ΔprtA prtA deletion mutant of WCH43 [EryR] Present study
WCH43::ΔsodA sodA deletion mutant of WCH43 [EryR] Present study
WCH43::ΔulaA ulaA deletion mutant of WCH43 [SpecR] Present study
WCH43::ΔvanZ vanZ deletion mutant of WCH43 [SpecR] Present study
prtA Ery X 5’-TTGTTCATGTAATCACTCCTTCTATTTATATAACTTCCAATAGATA-3’
prtA Ery Y 5’-CGGGAGGAAATAATTCTATGAGTATAGAAAAAAATGGTTTATGTACTGA-3’
prtA Flank F 5’-GAATGCATCTGATTTTTATCAGAC-3’
prtA Flank R 5’-TCTAAAACCTCTTTGTTTACGAGAG-3’
prtA UpSeq 5’-GAGCTTGGTTCCAAGTGGTTGATT-3’
sodA Ery X 5’-TTGTTCATGTAATCACTCCTTCTTTCTTTCTATATGAAAATGATAACGC-3’
sodA Ery Y 5’-CGGGAGGAAATAATTCTATGAGGAGGGAAGAATTGTTCTTCTCTTTTTAG-3’
sodA Flank F 5’-CTTTGCGGATGAGAAAATCGTGAT-3’
sodA Flank R 5’-GACAGATAAACCATAGTGTTGACGC-3’
sodA UpSeq 5’-GCCAATGTTCACGCCTTTTATCAAC-3’
ulaA Spec X 5’-TATGTATTCATATATATCCTCCTCTTGAATTGTTTTTGTAAGTTTATTATATA-
3’
ulaA Spec Y 5’-AAATAACAGATTGAAGAAGGTATAATATCTAGAAAAGGAGAAATAAAATGGTT-
3’
ulaA Flank F 5’-GCTATTAAAAAAATAGAGGAAGAAGGT-3’
ulaA Flank R 5’-GCTGGATCCACAGCCTCTGTAATTC-3’
ulaA UpSeq 5’-TCTTTGCAGTTTATGCGCCAGGTG-3’
vanZ Spec X 5’-TATGTATTCATATATATCCTCCTCGTTTGAAGCCGTCTTCAACAAACA-3’
vanZ Spec Y 5’-AAATAACAGATTGAAGAAGGTATAACTAATGATTAAAAAGGAGAATATAATG-3’
vanZ Flank F 5’-CTTAAGGAAGTTCTACTTGAGCCG-3’
vanZ Flank R 5’-GAAAACGCCGTGCATCTTCTCAGC-3’
vanZ UpSeq 5’-CAAGACTGGGGTTAAAGAACCCGT-3’
doi:10.1371/journal.pone.0141816.t001
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as described previously [36] and validated by PCR and sequencing to be in-frame deletion
mutation replacements. All PCR procedures were performed with the Phusion High Fidelity
Kit (FINNZYMES). The primer pairs used for construction and validation of the mutants are
listed in Table 1. In order to evaluate the growth rate of the mutants in comparison to the wild
type, bacterial strains were grown in serum broth (SB) and A600 monitored overnight on a
Spectramax M2 spectrophotometer (Millennium Science).
Virulence assessment of mutants
To assess the virulence potential of mutants, groups of 12 male mice were challenged i.n. with
approx 1 × 107 CFU of either mutant or wild type bacteria in 50 μl SB, under deep anesthesia.
The survival of mice (time to moribund) was monitored closely (four times daily for the first 5
days (and more frequently if they show signs of distress as outlined below), twice daily for the
next 5 days, and then daily until 14 days after challenge. During the monitoring period, the
condition of each mouse was measured based on a predetermined Clinical Record Score and
written on a Clinical Record Sheet approved by the Animal Ethics Committee of The Univer-
sity of Adelaide. Mice are humanely euthanized either by CO2 asphyxiation or by cervical dislo-
cation if they become moribund or show any evidence of distress. The following criteria were
considered sufficient evidence of distress to warrant such intervention in order to minimize
pain or suffering to the animals: loss of balance, extreme hyperactivity or other evidence of
meningitis or CNS involvement; severe weight loss (>20% body weight); ear temperature fall-
ing below 24°C; paralysis or extreme reluctance or inability to move freely, and/or refusal or
inability to eat or drink. Differences in survival times for mice between wild-type and mutants
were analyzed by the Kaplan-Meier survival (log-rank [Mantel-Cox] and Gehan-Breslow-Wil-
coxon) tests using GraphPad Prism v6 software.
Pathogenesis experiments
For pathogenesis experiments, S. pneumoniae derivatives with mutations in genes of interest
(ΔprtA, ΔsodA and ΔvanZ) and the isogenic wild-type strain (WCH16 or WCH43) were grown
separately in SB to A600 = 0.16 (approx. 5 × 10
7 CFU/ml). For this analysis, groups of 6 mice
were anesthetized by intraperitoneal injection of pentobarbital sodium (Nembutal; Ilium) at a
dose of 66 mg per g of body weight and separately challenged i.n. with 50 μl suspension con-
taining approx. 3 × 106 CFU of either wild-type or the isogenic mutant. At 48 h post-challenge,
mice from each separate infection experiment were sacrificed and bacteria were enumerated
from the nasopharynx, lungs and blood, as described previously [22, 23]. The experiment was
repeated once.
Results
In this work, we carried out a direct comparison of pneumococcal gene expression between the
nasopharynx and blood of mice in order to identify differentially expressed genes between the
two niches. The analyses were performed using existing transcriptomic data obtained from two
S. pneumoniae strains, WCH16 andWCH43, after intranasal challenge of mice.
Identification of differentially expressed genes between the nasopharynx
and blood
We carried out a two-color microarray comparison of mRNA extracted from pneumococci
harvested from the nasopharnyx and blood of mice at 48, 72 and 96 h post-infection in separate
challenge experiments with either WCH16 or WCH43. The comparisons yielded 114
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differentially regulated genes in the blood relative to the nasopharynx for WCH16, and 428
genes differentially regulated in the blood for WCH43, of which 62 differentially expressed
genes were found to be common to both strains (Fig 1A and 1B). Details of combined expres-
sion values for all the 62 genes are in S1 Table. Fully annotated microarray data have been
deposited (GEO accession number GSE73217).
Functional classification of differentially expressed genes
We utilized our recently developed comparative GO web application [34] to assess any differ-
ences in the functional categories of genes up-regulated either in the nasopharynx or blood,
with particular attention to molecular function and biological process. The analyses showed
that under “molecular function”, the GO protein distributions between the nasopharynx and
blood were significantly different (p = 0.0008; two-sample K-S test). GO groups involved in
transporter activity were significantly up-regulated in the nasopharynx relative to blood
[p = 0.01; Chi square test], while those involved in transcription factor (DNA binding) activity
were substantially up-regulated in the blood (Fig 2A and 2B). Similarly, under “biological pro-
cess”, the GO protein distributions between the two niches were significantly different
[p = 0.0043; two-sample K-S test] (Fig 2C and 2D), although this did not reach statistical signif-
icance for any of the GO groups identified between the two niches by Chi square test.
Contribution of up-regulated pneumococcal genes to colonization and
virulence
Earlier studies had shown that the pneumococcus undergoes spontaneous phase variation
between a transparent and an opaque colony phenotype in vitro, with the transparent pheno-
type commonly associated with nasopharyngeal colonization and the opaque variant being
favored in the blood [26, 37]. These findings led to the suggestion that phase variation might
provide important clues to the interaction of the pneumococcus with its host, the opaque phe-
notype being significantly more virulent than the transparent phenotype [26, 38]. Interestingly,
subsequent work in our laboratory indicated that niche-specific differences in expression of
selected pneumococcal virulence genes were not attributable to phase variation. In order to
eliminate the contribution of phase variation to selection of genes for further analysis, we ini-
tially compared gene expression of transparent pneumococci with those harvested from the
nasopharynx, and also compared gene expression of opaque pneumococci with those harvested
from the blood. We reasoned that such analyses would identify genes that are most likely to be
essential for either colonization, or important for blood invasion or systemic disease. We also
examined our existing in vivo transcriptomic comparisons of nasopharynx vs lungs, as well as
data from lungs vs blood comparisons to guide our gene selection. In this manner, only pneu-
mococcal genes that were either up-regulated in the nasopharynx or blood were selected for
further analyses, independent of colony phenotype.
We then set an arbitrary threshold of>2-fold regulation to select differentially regulated
genes in the two niches that are considered to be physiologically relevant. Consequently, 2 of
the up-regulated genes in the nasopharynx (SP_0766 [sodA] and SP_2038 [ulaA]) and 2 genes
up-regulated in the blood (SP_0049 [vanZ] and SP_0641 [prtA]) were selected for further anal-
ysis and validated by RT-PCR for both strains (Table 2). S. pneumoniaeWCH43 derivatives
with marked mutations in the 4 selected genes were constructed by targeted mutagenesis using
overlap PCR. The in vitro growth rate of WCH16 and all its isogenic mutants was similar over
a 3-hour period as well as overnight as judged by A600 measurements in serum broth on a Spec-
tramax M2 spectrophotometer (Millennium Science). For WCH43, growth of the sodAmutant
was slightly delayed (approx. 20 minutes) over the 3-hour growth period, as well as during
Pneumococcal Genes in Carriage and Blood Invasion
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Fig 1. Regulation of pneumococcal gene expression between nasopharynx and blood of mice
infected i.n. with WCH16 andWCH43. (A). Venn diagram of differentially expressed genes frommicroarray
comparisons of Nasopharynx (N) versus Blood (B) in WCH16 andWCH43. (B). Heat map showing regulated
gene expression; yellow to blue scales represent fold difference in mRNA level; yellow, up-regulation in
nasopharynx relative to blood; blue, downregulation in nasopharynx relative to blood.
doi:10.1371/journal.pone.0141816.g001
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overnight growth. Nevertheless, this delay in growth of the sodAmutant of WCH43 would not
account for its attenuation in mice, as similar result were obtained for the sodAmutant of
WCH16, as described below.
After intranasal challenge of mice, the ΔprtA, ΔsodAmutants and, to a lesser extent, the
ΔvanZmutant of WCH43 were significantly attenuated for virulence, while the ΔulaAmutant
was essentially as virulent as the wild type (Fig 3). To assess the involvement of prtA, sodA and
vanZ in colonization or blood invasion, we challenged groups of mice i.n. with approx. 3 × 106
CFU of either mutant or the isogenic wild-type WCH16 or WCH43 strain and harvested bacte-
ria from the nasopharynx, lungs and blood at 48 h post-infection. For WCH43, we found that
Fig 2. GO classification of pneumococcal genes differentially up-regulated in the nasopharynx and
blood of mice.Molecular functional categories of genes (A), up-regulated in the nasopharynx, and (B), up-
regulated in the blood. (C and D), Biological process categories of up-regulated genes in the nasopharynx
(C), and up-regulated genes in the blood (D).
doi:10.1371/journal.pone.0141816.g002
Table 2. Differential expression profiles of selected S. pneumoniaeWCH16 andWCH43 genes between Nasopharynx and Blood by microarray
analysis.
Gene IDa Gene annotation Fold change (Nasopharynx/Blood)
WCH16 WCH43
SP_0049 VanZ protein, putative -2.61 (-59.03)b -2.02 (-13.78)
SP_0641 Serine protease (PrtA) -2.45 (-34.80) -2.25 (-6.82)
SP_0766 Superoxide dismutase, manganese-dependent (SodA) 4.16 (7.15) 3.32 (3.39)
SP_2038 PTS system ascorbate-specific transporter subunit IIC (UlaA) 15.48 (22.94) 9.66 (278.20)
a Gene IDs were obtained from the genome of S. pneumoniae TIGR4 (serotype 4) as deposited in the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database.
b Data in parentheses represent corresponding real time RT-PCR expression values from comparisons of total mRNA from at least 2 independent
experiments.
doi:10.1371/journal.pone.0141816.t002
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only the ΔsodAmutant was significantly attenuated for colonization of the nasopharynx (Fig
4A), while the numbers of ΔprtA and ΔsodAmutants were significantly lower in lungs (Fig 4B)
and blood (Fig 4C) compared to wild type. However, while the numbers of the ΔvanZmutant
bacteria were generally lower in blood than those for the wild type, this did not reach statistical
significance. To verify these results, we repeated the pathogenesis experiment using WCH16
and its isogenic ΔprtA, ΔsodA and ΔvanZmutants. As observed for WCH43, the ΔsodAmutant
was also significantly attenuated for colonization of the nasopharynx (Fig 4D), However, the
differences in pathogenesis of the mutants in WCH16 in lungs (Fig 4E) and blood (Fig 4F) did
not reach statistical significance, consistent with our previous observations that WCH16 dis-
plays minimal lung and blood involvement during pathogenesis [39, 40].
Discussion
In spite of the availability of antimicrobial therapy and conjugate vaccines, S. pneumoniae con-
tinues to be responsible for massive global morbidity and mortality. The problems associated
with pneumococcal disease are largely due to our incomplete understanding of the molecular
mechanisms underlying pneumococcal pathogenesis. Therefore, successful control of pneumo-
coccal disease and identification of novel vaccine candidates will require a detailed understand-
ing of the molecular mechanisms and virulence determinants underpinning the development
of invasive pneumococcal disease (IPD). Such investigations will include a thorough examina-
tion of factors up-regulated during transition from nasopharyngeal colonization to invasive or
meningeal infection, in conjunction with developing an understanding of the regulatory mech-
anisms underpinning such translocation.
Fig 3. Survival times for mice after i.n. challenge with WCH43 and isogenic mutant derivatives.Groups
of 12 CD1 male mice were challenged i.n. with approx. 1 × 107 CFU of the indicated strains. Survival curves
were compared using log-rank [Mantel-Cox] and Gehan-Breslow-Wilcoxon) tests. (* P<0.05; ** P<0.01).
doi:10.1371/journal.pone.0141816.g003
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Fig 4. Pathogenesis of WCH43 (A-C) andWCH16 (D-F) and their isogenic mutant derivatives in male
CD1mice. Bacteria were enumerated from the nasopharynx (A, D); lungs (B, E) and blood (C, F) of each
mouse at 48 h post-infection (n = 12 per group per time-point). Horizontal line represents geometric mean;
horizontal broken line denote limit of detection (40 CFU). *, P < 0.05; ** P<0.01; unpaired t-test, one-tailed.
doi:10.1371/journal.pone.0141816.g004
Pneumococcal Genes in Carriage and Blood Invasion
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As an extension of our efforts toward identifying the critical determinants of pathogenesis,
we have used microarray analysis to do a direct comparison of pneumococcal gene expression
between the nasopharynx and blood of mice. This assessment was undertaken in order to iden-
tify the genes specifically up-regulated during blood invasion from the nasopharynx (“occult
bacteremia”), which is often a complication of pneumococcal carriage in young children [24,
41]. This is critical in the context of optimization of a multi-component protein vaccine that
targets all forms of pneumococcal disease, considering the hypothesis that many pneumococcal
virulence factors have dual roles in the maintenance of carriage and invasive disease [38, 42,
43].
Our analysis identified a number of common factors significantly up-regulated in the naso-
pharynx relative to blood in the two pneumococcal strains; not surprisingly, the vast majority
of the encoded proteins function in carbohydrate metabolism and/or transporter activity.
Mutation of one of the two genes up-regulated in the nasopharynx, sodA, resulted in significant
attenuation of virulence in a mouse intranasal challenge model, in agreement with previous
reports [42, 44]. In a pathogenesis experiment, there was significant reduction in numbers of
sodAmutant bacteria recovered from the nasopharynx and a concomitant significant reduction
in the lungs and blood at 48 hr post-challenge. These results are consistent with a significant
role for SodA in oxidative stress management [44, 45], suggesting it might be a good a drug tar-
get against carriage. However, deletion of ulaA (with a putative function of the encoded prod-
uct in transporter activity) did not have any effect on virulence, suggesting functional
redundancy.
We also analyzed the genes that were significantly up-regulated in the blood relative to
nasopharynx in the two pneumococcal strains. Most of the genes encode enzymes involved in
metabolism of cofactors, vitamins and amino acids, as well as those required for transcriptional
regulation of metabolites. This would be consistent with the need to up-regulate such factors
for sensing and adaptation to challenging environments such as the blood. For some of these
factors, their role in pneumococcal virulence is well documented. For instance, CbpA
(SpR_1995/SP_2190) has been shown to be involved in multiple stages of pneumococcal path-
ogenesis [43, 46–48]. Another protein, MalX (SP_2108), was shown to be important for coloni-
zation [49] and lung infection [42, 44]. Like CbpA, the finding in this study thatmalX is
significantly up-regulated in the blood relative to the nasopharynx suggests that it might also
be involved in multiple stages of pathogenesis, which would make it an ideal protein vaccine
candidate.
We then mutated 2 of the genes, prtA and vanZ, encoding a cell wall-localized subtilisin-like
serine protease (PrtA) and a putative vancomycin resistant protein (VanZ), respectively. The
prtAmutant was significantly attenuated in a mouse intranasal challenge model in the WCH43
background; the vanZmutant also exhibited a small, but statistically significant attenuation.
The attenuation of the prtAmutant is in agreement with a previous report [50], although in
that study, the challenge was via an intraperitoneal route, using a different pneumococcal
strain, D39 [50]. Interestingly, in our study, pathogenesis studies show significantly low num-
bers of WCH43 prtAmutant bacteria in the bloodstream of intranasally-challenged mice rela-
tive to wild-type bacteria, which would be consistent with its attenuated virulence, but in
contrast to the earlier study which showed more prtAmutant bacteria in the blood of intraperi-
toneally challenged mice [50]. Another recent study showed modest effects of a D39ΔprtA
mutation in lungs and blood of intranasally-infected mice [51]. A possible explanation for the
apparent contradiction in these results could be that expression of PrtA is more important for
pathogenesis and virulence of WCH43, while this effect is masked by other virulence factors
produced by D39 (which displays high grade bacteremia), suggesting strain-specific differ-
ences. This is further highlighted by our pathogenesis results with WCH16 prtAmutant.
Pneumococcal Genes in Carriage and Blood Invasion
PLOS ONE | DOI:10.1371/journal.pone.0141816 November 5, 2015 11 / 15
Moreover, the different routes of infection and challenge doses used in these studies could also
account for the discordant results. The discrepancy in attenuation of virulence of a specific fac-
tor in different pneumococcal backgrounds is not unprecedented, as was reported for cbpA-
[pspC-] [25, 43, 47, 52, 53] and psaR [54] mutants. With respect to VanZ, its specific role in
pneumococcal pathogenesis is yet to be described, although it was found to be essential for
lung infection [42] and its homolog has been shown to confer resistance to teicoplanin in
Enterococcus faecium [55].
It is as yet unclear how PrtA contributes to the virulence of S. pneumoniae. It was shown
previously that PrtA acts by cleaving apolactoferrin (the iron-free form of human lactoferrin)
to produce a lactoferricin-like peptide, which is highly bactericidal for pneumococci [56]. This
would suggest that expressing PrtA might be counter-productive, because anti-PrtA antibodies
could inhibit killing of the pneumococcus. Nevertheless, strongly reactive anti-PrtA antibody
was prominent in convalescent-phase human sera [50, 57, 58], and a prtAmutant was attenu-
ated for virulence as demonstrated in the present study. Therefore, more work, both in vitro
and in vivo, is needed to clarify the role of PrtA in the biology of S. pneumoniae, and to deter-
mine whether it is worthy of further consideration as a vaccine candidate.
Other workers have compared transcriptomes of pneumococci harvested from various in
vitro and in vivo sources by microarray analysis or RNA-Seq. For example, one previous study
[59] used in vitro alternatives for specific in vivo niches (e.g. co-culture with Detroit 562 cells to
mimic nasopharyngeal colonization; co-culture with type II pneumocytes to mimic lung infec-
tion). The workers further compared whole transcriptomes of a particular pneumococcal strain
(TIGR4) harvested in vitro (to mimic colonization) with whole transcriptomes of a different
pneumococcal strain (D39) harvested from mouse blood (to mimic invasive disease). Recently,
another group of workers [60] characterized pneumococcal RNA harvested from a human
respiratory epithelial cell line (to mimic lung infection), using S. pneumoniae EF3030, which
causes focal pneumonia in their infection experiments. Furthermore, Pettigrew et al. compared
transcriptional profiles of planktonic and biofilm-grown EF3030 with influenza A virus-dis-
persed bacteria. Genes that have been well characterized to play a prominent role in pneumo-
coccal pathogenesis and/or virulence (such as ply, pspA, cbpA,malX) were commonly
identified in those previous studies and in our study. Nevertheless, we are of the view that our
mouse intranasal infection model closely mimics natural progression of invasive pneumococcal
disease in humans; the use of multiple strains of different pathogenicity characteristics also
increases the likelihood of identifying common, novel genes that might be critical to pneumo-
coccal pathogenesis.
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